BGM (BGM Group) EBIT: $-1.86 Mil (TTM As of Mar. 2025)

What is BGM Group EBIT?

BGM Group BGM -4.16% 53 EBIT is $-1.86 Mil as of Mar. 2025. GuruFocus rates BGM with a GF Score™ of 53/100 and a GF Value™ of $1.24 (Possible Value Trap). The stock has 2 warning signs investors should review.

BGM Group's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2025 was $-2.14 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2025 was $-1.86 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. BGM Group's annualized ROC % for the quarter that ended in Mar. 2025 was -0.69%. BGM Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was -28.35%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. BGM Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was -3.26%.

BGM Group (NAS:BGM) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

BGM Group's annualized ROC % for the quarter that ended in Mar. 2025 is calculated as:

	ROC % (Q: Mar. 2025 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2024 )	+	Invested Capital (Q: Mar. 2025 ))	/ count )
=	-4.286 * ( 1 - 83.89% )	/	( (26.656	+	174.56)	/ 2 )
=	-0.6904746	/	100.608
=	-0.69 %

where

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	53.004	-	8.207	-	( 18.141	-	max(0, 8.776	-	29.769	+	18.141	))
=	26.656

	Invested Capital		(Q: Mar. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	207.393	-	18.291	-	( 14.542	-	max(0, 23.586	-	42.943	+	14.542	))
=	174.56

Note: The Operating Income data used here is two times the semi-annual (Mar. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

BGM Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2025 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2024		Q: Mar. 2025
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-4.286	/	( ( (14.911 + max(-1.38, 0))	+	(15.33 + max(-4.791, 0)) )	/	2 )
=	-4.286	/	( ( 14.911	+	15.33 )	/	2 )
=	-4.286	/	15.1205
=	-28.35 %

where Working Capital is:

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.543	+	5.05	+	0.803)	-	(8.207	+	0.569	+	0)
=	-1.38

	Working Capital		(Q: Mar. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(5.523	+	8.849	+	2.719)	-	(18.291	+	3.591	+	-3.5527136788005E-15)
=	-4.791

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

BGM Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2025 )
	=	-1.861	/	57.062
	=	-3.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BGM Group EBIT Related Terms

BGM Group EBIT Historical Data

* Premium members only.

The historical data trend for BGM Group's EBIT can be seen below:

BGM Group EBIT Chart

BGM Group Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

EBIT

Get a 7-Day Free Trial

6.05

2.95

2.52

-2.42

-0.36

BGM Group Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
EBIT	Get a 7-Day Free Trial											0.31	-2.73	-0.64	0.28	-2.14

BGM vs INCR, SCYX, CTOR: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BGM Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BGM Group EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BGM Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BGM Group's EV-to-EBIT falls into.

Save Embed

53GF Score

BGM Group Ltd BGM

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BGM Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.86 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of $-1.86 Mil mean?

BGM Group (BGM) has a EBIT of $-1.86 Mil as of Mar. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BGM Group.

Is BGM Group's EBIT too high?

BGM Group's current EBIT is $-1.86 Mil. Overall, BGM Group has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does BGM Group's EBIT compare to INCR and SCYX?

BGM Group's EBIT of $-1.86 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Drug Manufacturers company?

A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BGM Group. BGM Group's current EBIT is $-1.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BGM Group stock overvalued right now?

Based on GuruFocus' analysis, BGM Group (BGM) is currently considered Possible Value Trap. The stock's GF Value™ is $1.24, compared to a current price of $0.34 — trading 72.6% below its estimated fair value. The current EBIT is $-1.86 Mil. BGM Group's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For BGM Group (BGM), the current EBIT is $-1.86 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BGM Group (BGM) Overvalued in 2026?

Based on GuruFocus' analysis, BGM Group stock appears to be undervalued. The current stock price of $0.34 is trading 72.6% below its estimated GF Value™ of $1.24. GuruFocus considers BGM Group to be Possible Value Trap.

Key valuation signals for BGM:

EBIT: $-1.86 Mil
GF Value™: $1.24 vs. price of $0.34 (72.6% below fair value)
GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the BGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BGM Group Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies INCR SCYX CTOR ETST INIS TLPH IXHL ZYBT BTAI CPIX XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Address No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200

Website https://www.bgmgroupltd.com

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

53GF Score

Get the complete analysis for BGM

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34

Price

$1.24

GF Value

View BGM Analysis

See EBIT data for all stocks →